Contents

Search

pegaptanib

Mechanism of action: - vascular endothelial growth-factor antagonist

Related

macular degeneration

Specific

pegaptanib ophthalmic (Macugen)

General

small inhibitory antineoplastic agent (ib drug) enzyme inhibitor

References

  1. Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: 210216 (subscription needed) http://www.prescribersletter.com
  2. FDA Medwatch http://www.fda.gov/medwatch/safety/2006/safety06.htm#Macugen